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Abstract. In addition to its roles in hemostasis and
wound repair, the blood clot plays an underappreciated role
in innate immunity, where the established clot serves as a
barrier to microbial penetration into the internal milieu and
where the early clot entraps and immobilizes microbes that
have entered wounds to the integuments. In this report we
document the behavior of the pathogenic gram-negative
bacterium Vibrio harveyi that has been entrapped in the
fabric of the extracellular blood clot of one of its target
organisms, the Pacific white shrimp, Litopenaeus vannamei.
The freshly entrapped bacteria are held tightly by the clot,
losing even Brownian motility, but by 1 h post-entrapment,
a fraction of the bacteria have established small domains of
fibrinolysis that enlarge progressively, enabling bacteria to
escape from the clot’s embrace. Escape is dependent on the
actions of both serine- and metallo-proteases released from
the bacterial cells.
Introduction
Higher animals cope with invading pathogens by the
activities of a variety of defense systems involving elements
of the integuments and the extracellular matrix, specialized
immune defense cells, and effector proteins and peptides
that are found at the integumental surfaces and in the blood.
The cellular and humoral components function to neutralize
and clear the invading pathogens and the foreign molecules
introduced by pathogens. The fibrillar extracellular blood
clot is potentially an important element of the innate im-
mune system. The clot can be a mechanical barrier to the
entry of microbes through wounds to the integuments, can
entrap and immobilize microbes that have entered the
wound prior to the establishment of the mature clot (Bang,
1979; Dunn and Simmons, 1982; Rotstein, 1992; Isakova
and Armstrong, 2003), can bind microbial toxins (Arm-
strong et al., 2013), and can activate a variety of other
effector arms of the innate immune system (Opal and Es-
mon, 2003; Frick et al., 2006).
Pathogenic microbes show complex interactions with the
fibrin clot of mammals and arthropods. They may provoke
proteolytic lysis of the fibrin clot (see Armstrong, 2006;
Sun, 2006) or they may induce formation of the clot (Bang,
1979; Persson et al., 2003). The fibrils of the extracellular
blood clot of mammals and arthropods become decorated
with several of the proteins of the innate immune system
(Armstrong and Armstrong, 2003; Chaikeeratisak et al.,
2012), suggesting that, in addition to the entrapment and
binding of microbes, the clot may utilize this armament of
immune effector proteins to play an active role in protecting
the clot, in destroying entrapped microbes, and in seques-
tering and inactivating their toxic products.
The three taxa that have seen the best biochemical char-
acterization of the clotting process are the vertebrates (Furie
* To whom correspondence should be addressed. E-mail:
pbarmstrong@ucdavis.edu
Abbreviations: A2M, 2-macroglobulin; AEBSF, 4-(2-aminoethyl) ben-
zenesulfonyl fluoride hydrochloride, a serine protease inhibitor; DIC, dif-
ferential interference contrast microscopy; E-64, N-[N-(L-3-trans-car-
boxyirane-2-carbonyl)-L-leucyl]-agmatine, a cysteine protease inhibitor;
SSS, sterile shrimp saline.
Reference: Biol. Bull. 226: 102–110. (April 2014)
© 2014 Marine Biological Laboratory
102
and Furie, 2000), the chelicerate arthropods (Muta and
Iwanaga, 1996), and the crustaceans (Fuller and Doolittle,
1971a, b; Kopacek et al., 1993; Hall et al., 1999). In
vertebrates and chelicerates, the initiation of the polymer-
ization of the precursor structural protein into the fibrils of
the clot involves the proteolytic activation of a soluble
zymogen. The protolyzed zymogens, fibrin in vertebrates
(Weisel, 2005) and coagulin in chelicerates (Kawasaki et
al., 2000), assemble into the clot fibrils. The crustacean clot
is established by the transglutaminase-catalyzed covalent
cross-linking of an abundant plasma lipoprotein, variously
named clotting protein (CP) and very high density lipopro-
tein (VHDL) (Fuller and Doolittle, 1971a, b; Doolittle and
Riley, 1990; Hall et al., 1999; Wang et al., 2001; Maningas
et al., 2013).
The aquaculture of crustaceans has become an important
sector of the agricultural economy in several parts of the
world, with shrimp the mainstay of this industry (Leung and
Engle, 2006). An important economic challenge to shrimp
aquaculture is the susceptibility of shrimp to bacterial
pathogens (Lavilla-Pitogo et al., 1998; Flegel, 2012). Vibrio
harveyi is a serious pathogen in shrimp farming. Even
though a detailed understanding of its pathogenic attack on
shrimp remains elusive, its extracellular products, including
proteases, phospholipases, and hemolysins, are believed to
be the dominant virulent factors (Austin and Zhang, 2006).
In this report, we present the results of a study of the role
of the shrimp blood clot in the defense against bacterial
parasites. We use the gram-negative bacterium Vibrio har-
veyi as our test pathogen because it is responsible for major
lost productivity for those species of crustaceans that are
susceptible to infection; and we use the Pacific white
shrimp, Litopenaeus vannamei, as the host species because
its utility in aquaculture is limited by its susceptibility to
Vibrio infection (Flegel, 2012).
Materials and Methods
Animal cultivation
Specific-pathogen-free (SPF) Pacific white shrimp, Lito-
penaeus vannamei Boone, 1931, were provided to us by
Shaun M. Moss, Oceanic Institute, U.S. Marine Shrimp
Farming Program, 41-202 Kalanianaole Hwy, Waimanalo,
HI 96795-1820. The shrimp were acclimatized in artificial
seawater with salinity of 30 ppt, ambient temperature, and
continuous aeration for at least a week prior to use in
experiments. Hemolymph was collected from the ventral
cavity of the shrimp by aspiration into a 1-ml sterile syringe
fitted with a 23-gauge syringe needle and was used imme-
diately to set up the experimental situation before clotting
had been initiated.
Preparation of Vibrio harveyi strain 639
The gram-negative bacterium V. harveyi, which is an
important pathogen of aquacultured Pacific white shrimp,
was cultured at 30 °C in stirred suspension culture in sea-
water complete culture medium (seawater, 750 ml; distilled
water, 250 ml; Bacto tryptone, 5 g; yeast extract, 1 g;
glycerol, 3 ml) and Difco Marine Broth 2216 (BD Biosci-
ence) and was used when in log-phase growth. Bacteria that
were added to shrimp hemolymph prior to the initiation of
clotting were first washed free of culture medium by gentle
centrifugation into sterile shrimp saline (SSS) (15 mmol l1
CaCl2, 7 mmol l1 KCl, 12.5 mmol l1 MgCl2  6 H2O, 7.4
mmol l1 NaHCO3, 336 mmol l1 NaCl2, pH 7).
To produce “conditioned” bacterial culture medium, a
clonal colony of bacteria grown on Difco Marine Agar 2216
(BD Bioscience) was transferred to 5 ml of Difco Marine
Broth 2216. The culture was incubated overnight on a rotary
shaker at 30 °C, 180 rotations per min. Bacteria-conditioned
culture medium was freed of bacterial cells by centrifuga-
tion at 16,000  g for 10 min and used immediately after
preparation.
Efficiency of bacterial entrapment by shrimp hemolymph
clots
Shrimp hemolymph collected without anticoagulant so-
lution was heated to 55 °C for 30 min to obtain unclottable
hemolymph. Equal numbers of washed bacteria diluted in
either SSS or unclottable hemolymph served as negative
control groups. For the experimental group, the same num-
bers of V. harveyi were diluted in normal hemolymph; the
sample was allowed to clot for 30 min at room temperature;
and then the clot was removed, leaving clot-free serum. The
concentrations of bacteria in control and serum preparations
were determined by hemocytometer counts. Because the
bacteria were motile, multiple digital photomicrographs
were made of the hemocytometer with a Plan Neofluar
40/0.75 objective, and cell numbers were determined by
counts made from the photomicrographs.
Microscopic examination of the blood clot
The method previously used for microscopic examination
of the blood clot of the American horseshoe crab, Limulus
polyphemus (Armstrong and Rickles, 1982), was adapted
for the study of the shrimp clot. Shrimp plasma was col-
lected without anticoagulant, and log-phase V. harveyi cells
were prepared as described above. Pre-chilled shrimp he-
molymph was spread as a thin layer on microscope cover-
glasses or mixed with a saline suspension of log-phase V.
harveyi cells before being spread on a coverglass, which
was then incubated at room temperature for 30 min in a
moist chamber. The blood cells attached to the coverglass
surface and the plasma positioned above the cells clotted in
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a few minutes. These preparations were then inverted above
a volume of seawater complete bacteriological culture me-
dium on a microscope slide. Small chips of microscope
coverglass at the four corners of the slide supported the
coverglass above the surface of the slide, and the prepara-
tion was sealed with a molten mixture of paraffin and
beeswax painted around its perimeter. This system permit-
ted extended observation of the blood clot with oil-immer-
sion objectives with the light microscope. Fibrinolytic de-
struction of the clot was quantified by determining the
fraction of entrapped bacteria that eventually established
domains of fibrinolysis, as detected by a resumption of
swimming motility and by the progressive enlargement of
these fluid domains, as estimated by the maximum bound-
aries accessible to individual swimming bacteria. Five vi-
sual fields of a preparation were observed by phase contrast
microscopy at 0, 30, 60, 90, and 120 min after initial
bacterial entrapment, and the fraction of swimming bacteria
was determined by comparing short photographic exposures
and long exposures made at reduced illumination intensity
obtained by inserting 0.5- and 0.03-neutral density filters
into the light path and optimizing exposure time for this
reduced lighting intensity. Swimming bacteria presented as
sharp images in the short exposures, but as blurred images
in the long exposures, whereas immotile cells presented as
sharp images in both the short- and long-exposure photo-
micrographs. To estimate the areas of clot fibrinolysis,
single microscopic fields were video recorded for 1-min
intervals at these same time points, and the areas of the clot
traversed by individual swimming bacteria were traced from
the video records. The planar areas accessible to the indi-
vidual bacterial cells were calculated using the ImageJ
program, ver. 1.47 (National Institutes of Health). Various
protease inhibitors were included in the system to identify
the classes of proteases involved in bacteria-mediated fibri-
nolysis.
Fibrinolysis of the shrimp clot by Vibrio harveyi
proteases
Various protease inhibitors of known selectivity for their
class-based protease inhibition capabilities were added to
clots containing entrapped bacteria to identify the classes of
proteases involved in bacteria-mediated fibrinolysis, with
the expectation that inhibition of bacterial escape would
identify the proteases that were necessary for clot fibrino-
lysis. In parallel, we investigated the ability of culture
medium that had previously supported the growth of V.
harveyi to degrade shrimp blood clots. The shrimp clots
prepared on coverglasses as described above were incubated
at 37 °C for 3 h with Difco Marine Broth that had supported
overnight growth of bacteria, and then were stained with
GelCode Blue Stain Reagent (Pierce) to stain the clot pro-
tein that remained after treatment. Protease inhibitors were
added to bacteria-conditioned culture medium to assist our
identification of the classes of proteases that are required for
fibrinolysis. Final concentrations of individual inhibitors are
as followed; 1,10-phenanthroline, 2 mmol l1 ; AEBSF, 1
mmol l1; E-64, 15 mol l1; and Pepstatin, 10 mol l1.
For the top panel of Figure 5A, a 50-l drop of test medium
was placed at the center of a uniform layer of clot. Clot
fibrinolysis manifested as a central zone of loss of stained
material. For the second panel of Figure 5A, a 5-l sample
of clot was positioned in the center of the field for each
sample of the bottom panel and then submerged in a 0.5-ml
drop of test medium. Fibrinolysis was manifested as a
reduced amount of stained protein in the 5-l centrally
positioned clot.
Results
Bacterial entrapment by the shrimp blood clot
The blood clot represents a potential barrier to entry to
the internal milieu across wounds to the integument, both by
capturing bacteria as the clot is forming and by physically
blocking entry after clotting is complete. To estimate the
entrapment efficiency of the developing blood clot of the
shrimp, a fixed number of washed log-phase, free-swim-
ming Vibrio harveyi cells were mixed with freshly drawn
hemolymph, and the hemolymph was then allowed to clot
(experimental sample). Controls involved parallel bacterial
preparations suspended in sterile shrimp saline (SSS) or
unclottable hemolymph (55 °C heated plasma) (Fig. 1). The
result revealed that approximately 84% of the V. harveyi
cells were removed from suspension (entrapped in the clot
or cytolysed) during the clotting process.
Microscopic visualization of extracellular blood clots
Microscopic observation of the shrimp blood clot allowed
a study of the establishment of the clot and the fate of
bacteria that had been captured by the clot. A thin layer of
freshly collected, unclotted hemolymph, with or without
added log-phase V. harveyi bacteria, was spread on a mi-
croscope coverglass and maintained at room temperature in
a moist chamber to prevent drying. After clotting had oc-
curred, this was mounted above a microscope slide for
microscopic inspection. Although DIC microscopy visual-
ized the blood cell secretory granules well, phase contrast
microscopy was better in visualizing clot fibrils and bacteria
entrapped in the clot. The blood cells attached to the surface
of the coverglass. In decapods, the distinction is made
between the hyaline cells, which are small and nearly
agranular; the semi-granular cells, which are larger and
whose cytoplasm contains smaller secretory granules; and
the granular cells, which are larger still and contain an
abundance of cytoplasmic secretory granules (Hose et al.,
1990). The hyaline cells underwent cytolysis, leaving an
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intact-appearing nucleus (Fig. 2B and 2B’; white arrow-
heads). The semi-granular and granular cells remained in-
tact and flattened on the glass surface (Fig. 2B). The plasma
layer above the blood cells underwent clotting (Fig. 2B and
2B’; black arrowheads). It has been suggested that the
cytolysis of the hyaline cells activates the blood clotting
Figure 1. Capture of log-phase Vibrio harveyi by the blood clot of Litopenaeus vannamei. Control, sterile
shrimp saline (SSS) and unclottable shrimp plasma; experimental, freshly drawn whole hemolymph. Three trials
were done in each group. An asterisk represents a significant difference (P  0.05) among the experimental
groups.
Figure 2. Structure of the shrimp blood clot with (A’, B’, C’) and without (control, A, B, C) addition of
Vibrio harveyi. (A, A’) Bright-field microscopy; (B, B’) phase contrast microscopy; (C, C’) DIC microscopy.
Black arrowheads indicate clot fibrils, and thick white arrowheads indicate cytolyzed hyaline cells. Bacterial
cells, which can be seen as dark, rod-shape cells in B’ (thin white arrows), were immobilized in the fabric of the
clot. Micrographs represent at least three fields of view per sample. Scale bar, 50 m.
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system because the earliest foci of clot formation coincide
with these lysed cells (Hardy, 1892; Tait and Gunn, 1918).
Bacteria added to the hemolymph prior to clotting became
physically entrapped within fabric of the clot (thin white
arrows, Fig. 2B’). We saw no evidence for cytolysis of the
entrapped bacteria (data not shown), suggesting that the
principal process for bacterial removal from the blood (Fig.
1) was physical entrapment by the clot.
Vibrio harveyi is able to escape from the shrimp clot
Most of the entrapped bacterial cells were initially com-
pletely immobilized: lacking their former active flagellum-
based swimming locomotion and lacking even Brownian
thermal motion. At later times, increasing numbers of the
entrapped bacteria resumed their flagellar swimming in
small fluid volumes that appeared within the clot and im-
mediately surrounded each of the individual swimming cells
(Fig. 3A; yellow overlays). By 2 h, about a third of bacteria
were seen swimming about in these little chambers. The
sizes of the fluid chambers could be determined by tracing
the motility of individual bacterial cells from video records
1 min in duration made at regular intervals from the same
microscope field (Fig. 3A). With time, the volumes of each
individual chamber surrounding the motile bacteria progres-
sively enlarged, as revealed by progressively larger territo-
ries accessed by the individual swimming bacterial cells
(Fig. 3B). Calculated by the ImageJ program, the fibrino-
lysis areas occurred in V. harveyi entrapping blood clots at
0, 30, 60, 90, and 120 min were 0.015, 0.104, 0.486, 0.926,
and 1.448 mm2, respectively. The total area in the observed
field is 7.237 mm2. Figure 3B shows an initially slow
increase in the average area of fibrinolysis, followed by a
period of exponential increase by 2 h. When the edges of an
ever-enlarging volume of fibrinolysis reached the surface of
the clot, the bacterium was able to escape from the clot into
the surrounding environment.
Figure 3. Escape of bacteria from confinement by the blood clot, as shown by restoration of swimming
activity. (A) Photomicrographs of the same fields of blood clot taken every 30 min after initial clotting. Initially,
the bacterial cells are held firmly, but by 30 min some of them have resumed swimming in small volumes of fluid
(arrows) where the clot has been solubilized. Yellow overlays indicate the borders of the fluid chambers. These
chambers enlarge over time, merging with one another starting at 60 min after clotting. By 120 min, one-third
of the bacteria were free of the clot. Scale bar, 20 m. (B) Composite data obtained by measurement of the planar
areas of fibrinolysis zones of three replicates. Error bars, 1 S.E.M. (One-way ANOVA, P  0.05).
106 V. CHAIKEERATISAK ET AL.
Both serine- and metalloproteases released from Vibrio
harveyi cells are required for fibrinolysis
Vibrio-mediated fibrinolysis was dependent on proteo-
lytic destruction of the fabric of the clot. The effect of
protease inhibitors on bacterial escape was assessed by the
suppression of the reestablishment of active swimming mo-
tility at 2 h after initial entrapment. Fibrinolysis was sup-
pressed by the inclusion of the Halt Protease Inhibitor
Cocktail (Thermo Scientific Cat 1860932) diluted 100-fold
to the standard working concentration. This mixture of
protease inhibitors contains the serine protease inhibitors
AEBSF (1 mmol l1) and aprotinin (0.8 mmol l1); the
amino-peptidase inhibitor bestatin (50 mol l1); the cys-
teine protease inhibitor E-64 (15 mol l1); the broad-
spectrum protease inhibitor leupeptin (20 mol l1); and
the aspartyl protease inhibitor pepstatin A (10 mol l1).
Because this cocktail of inhibitors did not affect the active
swimming motility of V. harveyi cells maintained in sus-
pension culture, the inhibition of bacterial escape is inde-
pendent of cytotoxic effects. Because 1 mmol l1 AEBSF
alone suppressed bacterial escape (Fig. 4), it is suggested
that serine proteases are necessary for bacterial-mediated
fibrinolysis. Bacteria-derived metalloproteases appear to
also be required because fibrinolysis is suppressed by the
inclusion of 2 mmol l1 1,10-phenanthroline in the absence
of other inhibitors. The inhibitors E-64 and pepstatin fail to
suppress fibrinolysis (Fig. 5A). This suggests that both
bacterial serine- and metallo-proteases are required for fi-
brinolytic attack on the shrimp blood clot and that cysteine-
and aspartyl-proteases are not required for fibrinolysis. The
arthropod blood clot is extensively cross linked by intermo-
lecular N(-glutamyl)lysine side chain cross links, which
may confer a sufficient resistance to proteolytic attack,
thereby necessitating the synergistic actions of both serine-
and metallo-proteases for successful fibrinolysis by the suite
of proteases that are secreted by V. harveyi.
In addition to the fibrinolytic effects of bacterial secre-
tions, the shrimp blood cells that attach to the glass substra-
tum of the observation chambers suffer morphological dis-
figurement when adjacent to the clot-entrapped bacteria
(Fig. 5B; arrows). This might be due to a protease-mediated
reduction of adhesiveness of the blood cells from the glass
surface or might be a response to cytotoxic agents released
from the bacterial cells.
Discussion
The principal imperative for all organisms is to reproduce
and transmit their genes to the next generation. Parasitism,
and the attendant disease and premature death, is an impor-
tant impediment to this imperative. A first line of defense is
the integument that isolates the internal milieu of metazoans
from the external environment. The immune system, with
its ability to eliminate and sequester pathogens and their
toxic products from the surfaces of the integuments and
from the internal milieu, is the second line of defense.
One of the first defense systems that parasites encounter
Figure 4. Effect of protease inhibitors on the entrapment of Vibrio harveyi cells in the clot at 2 h. Control,
no inhibitors; Halt, 1 Halt Protease Inhibitor Cocktail; AEBSF, a serine protease inhibitor; E-64, a cysteine
protease inhibitor; pepstatin, an aspartyl protease inhibitor. Only HALT and AEBSF significantly suppressed
bacterial escape from the clot.
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after successful penetration of the integuments of metazoans
is the extracellular blood clotting system. The fibrin clot in
vertebrates, the coagulin clot of chelicerate arthropods, and
the extracellular clot of crustaceans, established by the
transglutaminase-mediated covalent crosslinking of an
abundant plasma protein, variously identified as “clotting
protein” (CP) or “very high-density lipoprotein” (VHDL),
represent well-characterized examples of the extracellular
matrix that is formed at wound sites. These clots function to
staunch bleeding, as a substrate for invasion of wound-
healing tissue cells, and as an arm of the innate immune
system. In this capacity, the fully established clot, like the
intact integuments, presents a mechanical barrier to pene-
tration into the internal milieu. As demonstrated by the
present study, the extracellular clot entraps microbes during
its establishment at wound sites. Suppression of the blood
clotting system rendered shrimp more susceptible to viral
and bacterial infection, consistent with the notion that the
blood clotting system is essential to immunity (Maningas et
al., 2008). Entrapment of the virulent pathogen Vibrio har-
veyi is relatively short-lived. A significant fraction of the
entrapped bacterial cells secrete sufficient quantities of
Figure 5. Protease-based fibrinolysis of the shrimp blood clot. Degradation of the clot by Vibrio-conditioned
culture medium was inhibited by MIX (1 Halt Protease Inhibitor Cocktail supplemented with 1,10-phenan-
throline); by 1,10-phenanthroline (a metallo-protease inhibitor); and by AEBSF (a serine protease inhibitor); but
not by E-64 (a cysteine protease inhibitor), pepstatin A (an aspartyl protease inhibitor), or the positive control
(no protease inhibitors). Negative control, sterile Difco Marine Broth 2216). Images are representative of three
independent trials. (A: Top panel) A 50-l drop of test medium was placed at the center of a uniform layer of
clot. (A: Lower panel) A 5-l sample of clot was positioned in the center of the field for each trial and was then
submerged in a 0.5-ml drop of test medium. (B) Phase contrast micrographs of clots stained with GelCode Blue
Stain Reagent (Pierce). Arrows indicate morphologically deformed blood cells next to the entrapped bacteria.
Scale bar, 50 m.
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fibrinolytic proteases to overwhelm the protective actions of
the protease-binding protein, 2-macroglobulin (A2M),
which binds to the clot fibrils during clot formation and
slows their degradation by fibrinolytic proteases (Chaikeer-
atisak et al., 2012). But eventually, even isolated bacteria
entrapped in the clot secrete sufficient quantities of pro-
teases to swamp the protective actions of A2M, and fibrino-
lytic degradation can begin.
It is suggested that the fibrinolytic proteases of V. harveyi
operate as a suite of virulence factors that play an important
role in establishing the successful infection of the shrimp
host. This proposal could be investigated by comparing the
infectivity and pathologic potential of wild-type strains of
V. harveyi with strains that lack one or more of the essential
fibrinolytic enzymes. The experimental literature contains
several examples of bacterial parasites of mammals in
which fibrinolytic proteases play an essential role in viru-
lence ( reviewed in Armstrong, 2001, 2006).
To date, several extracellular proteases belonging to V.
harveyi have been identified: a 22-kDa cysteine protease,
which is an important exotoxin (Liu et al., 1997; Liu and
Lee, 1999), and three alkaline metal-chelator-sensitive pro-
teases (Fukasawa et al., 1988a, b). Other species of Vibrio
have been found to secrete serine (Park et al., 2009) and
metalloproteases (Chang et al., 2005; Kwon et al., 2007)
with fibrinolytic activities to proteins of the human clotting
system. To our knowledge, this present study is the first to
report a similar situation in arthropods in which an arthro-
pod pathogen is allowed to interact with an arthropod blood
clot. It is interesting in the present system that the syner-
gistic actions of both serine- and metallo-proteases are
required for successful proteolytic destruction of the shrimp
clot.
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